Financials climbed across the board in anticipation that a new Trump administration will take a friendlier approach to Wall ...

In a report released today, Cole McGill from Stifel Nicolaus maintained a Buy rating on Lithium Americas (Argentina) Corp. (LAAC – ...

Investing.com -- Shares of Barry Callebaut (SIX: BARN) rose following its results, which showed a stronger-than-expected ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the Stifel 2024 Healthcare Conference on Tuesday, ...

Cornell Belcher, Brilliant Corners Research's founder and president, and Brian Gardner, Stifel's chief Washington policy ...

In a report released today, Matthew Sheerin from Stifel Nicolaus maintained a Hold rating on Sensata (ST – Research Report), with a price ...

Shares of Bowlero Corp ( NYSE: BOWL) are building on Monday's after-hours gains and are up 16% from the previous close as the ...

Election Day is just about here, marking an end to the unpredictable ride that has been the 2024 presidential race following ...

A few days ago, it said it had sold off a small portion of its wealth management business to Stifel Financial Corp. for up to ...

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock sharply ...

JPMorgan analysts noted the 8% weight loss at the highest dose is more than any of the competitor oral drugs that are in development. Analysts led by Hardik Parikh called it a "great outcome" and ...